XSHE
300138
Market cap685mUSD
Jul 10, Last price
9.81CNY
1D
1.98%
1Q
-18.32%
Jan 2017
5.47%
IPO
22.31%
Name
Chenguang Biotech Group Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ChenGuang Biotech Group Co., Ltd. is a key player in the development and production of natural ingredients. Its extensive product catalog encompasses natural colorants, including paprika and marigold oleoresins, as well as turmeric. The company also manufactures a diverse array of spice extracts and essential oils, such as capsicum oleoresin, Sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil. Furthermore, ChenGuang Biotech provides a variety of nutritional and pharmaceutical extracts like lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts. Rounding out its offerings are various oils and protein products, specifically grape seed, walnut, safflower, flaxseed, and cottonseed oils, alongside natural lutein and dephenolized cottonseed protein. These versatile ingredients are widely utilized across sectors such as food, beverages, cosmetics, baking, healthcare, and animal feed. Established in 2000 and based in Quzhou, China, the company has a global operational footprint, serving customers across Europe, the Americas, Australia, Asia (including China, Russia, Japan, and Korea), and Africa.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2021‑00 | 2020‑12 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||